At ImmunoWay® Biotechnology, our mission is to accelerate the pace of biomedical innovation by developing unparalleled antibody solutions that illuminate the intricacies of life. We strive to bridge the gaps between science and medicine, connecting the dots between discovery and diagnosis, treatment, and cure.

Core Competencies

We pride ourselves on our diversified antibody platform, which includes a wide range of Primary Antibodies and ELISA Kits custom-tailored to meet the needs of researchers globally. Some of our newest additions to our extensive Immunoreagent portfolio consist of:

◎ NanobodyAI™ (Nano Antibodies): This robust antibody class is a rising star with massive potential and benefits for research and development. It has been engineered with an unparalleled Trillion-level Phage Display Nanobody Library.

◎ Mouse PathoELITE™ (Monoclonal Antibodies): These Pathological grade antibodies are built to carry out the best Immunohistochemical analysis. They possess the specificity, sensitivity, and low lot-to-lot variation that is essential for reliable experimentation.

◎ Rabbit PT® (Monoclonal Antibodies):  These Research Use Only antibodies were developed utilizing cutting-edge Recombinant DNA technology. Our antibodies are meticulously engineered and preserved to minimize lot-to-lot variation, ensuring that researchers can depend on the quality and performance of our products for their experiments.

◎ Multiplex IHC Kits: Vivid depiction of cellular composition, spatial arrangement, and multidimensional analysis of multiple targets in tissue samples. Our Immunohistochemistry Kit formats provide flexible, convenient, and high-throughput IHC results.

Future Advancements

As we step boldly into the future, we are thrilled to unveil our latest offerings that embody our commitment to innovation and excellence. Slated for the new year of 2025 are proud to announce the following:

◎ PolyVision™: Enjoy greater enhanced signal amplification with Ready-to-Use Polymer HRP Secondary Antibodies. Achieve desirable IHC results in just 30 minutes of incubation.

◎ Patho3in1™: Our Patho3in1™ solution is designed to streamline your workflow, combining three essential functions into one powerful tool. With this innovative approach, we are not only reducing experimentation time but also enhancing performance in Immunohistochemical analysis.

◎ DARPinAI™: Our DARPinAI™ technology harnesses the power of genetically engineered antibody mimetic proteins, creating groundbreaking opportunities in protein-to-protein binding. This pioneering class of small-protein therapeutics promises versatile applications in both diagnostics and therapeutics.

With a global footprint and a passion for excellence, we are committed to harnessing the power of antibodies to improve human health and well-being. Our pioneering spirit, collaborative culture, and relentless pursuit of innovation propel us forward, driven by the thrill of discovery and the promise of a brighter future.

Through our work, we aim to:

● Illuminate the mysteries of biology, one antibody at a time

● Enable groundbreaking research and discoveries

● Foster a culture of innovation, collaboration, and inclusivity

● Empower scientists, researchers, and clinicians to create a healthier world

Join us on this extraordinary journey, as we push the boundaries of what is possible and redefine the landscape of life sciences. Together, let's unlock the secrets of the immune system and create a brighter, healthier future for all.